SURVYR

XXII

22nd Century Group, Inc.
$0.10
−$0.01 (7.52%)Oct 28 close
Consumer Defensive CompareTechnicals
1M3M6M1Y2Y
-100%-70%-41%-11%+18%Oct 2025Oct 2026Apr 202652w high $540.0052w low $0.20
XXIISPY
Wall St. Highest PT $612.83 (+631032.9%) Wall St. Avg PT $502.32 (+517222.3%)
$0$210$419$629$839POC $17Hi $613Avg $502
Underwater Drawdown %Max DD -100.0%Current -100.0%
0.0%-100.0%
Relative Strength vs SPY-113.9% vs SPYUnderperforming
+132%0%-132%
1W
−$0.18 (64.43%)
1M
−$0.86 (89.83%)
3M
−$3.62 (97.39%)
6M
−$32.10 (99.70%)
YTD
−$230.90 (99.96%)
1Y
−$452.90 (99.98%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Wall Street & Morningstar coverage
Wall Street consensusNo covering analysts on file for XXII
Analyst price targetsNo target range on file
Morningstar star ratingNot rated
Checked Wall Street & Morningstar feeds · All analyst rating changes ›
Recent analyst rating changes · 10
Reiterated
2023-08-23 · Roth MKM reiterated Buy on XXII
Downgrade
2023-08-17 · Alliance Global Partners downgraded XXII from Buy to Neutral
Reiterated
2023-08-15 · Dawson James reiterated Buy on XXII
Downgrade
2023-08-15 · TD Cowen downgraded XXII from Outperform to Market Perform
Reiterated
2023-07-03 · Dawson James reiterated Buy on XXII
Reiterated
2022-03-04 · Dawson James reiterated Buy on XXII
All analyst rating changes ›

Third-party ratings, not SURVYR.'s views.

Key stats & company

Market value$154.0K
P/E (last 12 months)0.0
P/E (next 12 months, estimated)-0.0
52-week range$0.20 – $540.00
Revenue growth (latest quarter vs a year ago)-40.4%
Dividend yieldNo dividend

What they do

22nd Century Group, Inc., a tobacco products company, manufactures, distributes, and sells proprietary new reduced nicotine tobacco products in the United States. The company offers reduced nicotine content tobacco and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.

Consumer Defensive · Tobacco
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

No sector grades for XXII yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth
Outside this model's universe or screens
 Momentum Top 15
Outside this model's universe or screens
 Momentum Blend
Not in the current book
 New Highs Growth
Outside this model's universe or screens
 SURVYR. Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
 SURVYR. Physical AI Grid & Power
Outside this model's universe or screens
 SURVYR. Long Book
Not in the current book

Earnings & events

XXII earningsNext report in 6 days
Next report · quarter Sep 2026
Tue Nov 3, 2026Before the open
EPS consensus-$3.00
Revenue consensus$0
Last 4 quarters · EPS vs estimate
May 7, 2026-$361.60est -$24.00−1406.7%Below estimates
Mar 26, 2026-$117.80est -$42.00−180.5%Below estimates
May 15, 2024-$2738608.90est -$4918318.06+44.3%Above estimates
Mar 28, 2024-$17139593.25est -$9538556.25−79.7%Below estimates

In line = within 1% of the estimate.

Source: Yahoo Finance · refreshed 2026-10-22 19:56:39 ET
23-0323-0523-0823-1124-0324-0526-0326-05-29062774.700.00
EstimateActual (beat)Actual (miss)

Quarterly revenue

QuarterRevenueYoY
2026-06-30$1.3M-40.4%
2026-03-31$1.3M–
2025-12-31$1.0M–
2025-09-30$1.5M–
2025-06-30$2.2M–

News & catalysts

More news
22nd Century Group Preliminarily Reports Third Quarter Financial Results
GlobeNewswire · Oct 22
BC-Most Active Stocks
Associated Press · Oct 22
22nd Century Same Store Unit Sales for Pinnacle VLN® and Pinnacle Pure Surge 161%
GlobeNewswire · Oct 15
22nd Century Group's Reduced-Nicotine Tobacco Platform Positioned to Support France's Nicotine-Reduction Initiative
GlobeNewswire · Sep 28
22nd Century Group Urges Policymakers and FDA to Enact and Implement the Reduced Nicotine Content Standard, Citing Years Without a Final Rule
GlobeNewswire · Sep 24
Rating changes
Reiterated
2023-08-23 · Roth MKM reiterated Buy on XXII
Downgrade
2023-08-17 · Alliance Global Partners downgraded XXII from Buy to Neutral
Reiterated
2023-08-15 · Dawson James reiterated Buy on XXII
Downgrade
2023-08-15 · TD Cowen downgraded XXII from Outperform to Market Perform
Reiterated
2023-07-03 · Dawson James reiterated Buy on XXII
Reiterated
2022-03-04 · Dawson James reiterated Buy on XXII

Third-party analyst actions, not SURVYR.'s views. All rating changes

Stats refreshed 2026-10-22 19:56:39 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Coteau 0.9 · Oct 21, 2026